The Progress & Ongoing Challenge of 3D Bioprinting Cardiac Tissue

In the recently published ‘3D bioprinting and its potential impact on cardiac failure treatment: An industry perspective,’ authors Ravi K. Birla and Stuart K. Williams explore the potential for tissue engineering in cardiac medicine, and the eventual assembly of a bioprinted heart.

While heart failure usually requires a transplant, it can be challenging to find a suitable donor. Once a transplant is completed, there is a long road ahead too via a permanent need for immune suppression therapy—treatment that is hard on patients. The usual survival rate for patients is typically under 13 years.


Read Article Here.

More News